Cardlytics Q2 FY26 net loss widens to $14.9 million; revenue drops 36% to $36.9 million YoY

• Cardlytics posted Q2 revenue of $36.9 million, down 36% year over year; GAAP net loss widened to $14.9 million.
• Non-GAAP billings fell 34% to $65.5 million; adjusted contribution dropped 32% to $21.3 million.
• Non-GAAP adjusted EBITDA eased 43% to $1.7 million; monthly qualified users declined 17% to 185.4 million.
• CEO Amit Gupta said margins improved each month in the quarter, citing new advertiser relationships and deeper financial-institution partnerships.
• For Q3, Cardlytics guided billings of $61 million-$67 million; revenue of $34 million-$39 million, adjusted EBITDA of $0-$3 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cardlytics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202608051601BIZWIRE_USPR_____20260805_BW323513) on August 05, 2026, and is solely responsible for the information contained therein.